News
March 18, 2020

LOINC team actively working to expand tracking codes for coronavirus

LOINC code to aid in tracking of coronavirus

With the coronavirus now a pandemic, the LOINC team at Regenstrief is working continuously to create new codes to help public health officials around the globe track cases of the virus. Coordinating with the U.S. Centers for Disease Control and Prevention (CDC), public health and reference labs, and in vitro diagnostic manufacturers, the team has created about two dozen new codes to identify lab tests and results related to SARS-CoV-2 and COVID-19.

The codes are part of the LOINC® (Logical Observation Identifiers Names and Codes) terminology system, created and maintained at Regenstrief, that is used around the world to identify laboratory and other health observations. The standardized terms allow data to be collected and exchanged across health systems. This is especially important during outbreaks of disease. LOINC is available free of charge.

The use of these new codes will make it easier to track cases of COVID-19 in the United States and around the globe. With more complete tracking and data, health leaders can better study the virus and create strategies to contain the outbreak.

The team also created codes during other outbreaks such as Zika in 2015/2016 and SARS in 2013, among others.

LOINC continues to develop more terms for the virus and is welcoming additional requests.

You can find the list of terms here, as well as information related to SARS-CoV-2 and COVID-19 here.

In light of the pandemic, LOINC is hosting a virtual meeting on March 26 at 10 a.m. to discuss the current situation and answer questions related to LOINC coding for SARS-CoV-2.  The event is free, and everyone who is interested is invited to attend.

Sign up for the SARS-CoV-2/COVID-19 Virtual Meeting.

About Regenstrief Institute

Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its researchers are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform practice and improve the lives of patients around the globe.

Regenstrief Institute is celebrating 50 years of healthcare innovation. Sam Regenstrief, a successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.

About LOINC®

LOINC was created in 1994 at Regenstrief Institute in an effort to facilitate interoperability in healthcare. There was a growing trend to send clinical data electronically between healthcare entities, a practice that is integral today. Today, the LOINC coding system contains more than 92,000 terms for everything from a serum alpha 1 antitrypsin level to a zygomatic arch x-ray report. For each concept, LOINC covers many other rich details, such as synonyms, units of measure, and carefully crafted descriptions.

Related News

Researchers to study online therapy’s potential to prevent cognitive decline in ICU survivors

Researchers to study online therapy’s potential to prevent cognitive decline in ICU survivors

Indianapolis – Researchers from Indiana University Indianapolis, Regenstrief Institute and the IU School of Medicine’s Indiana Alzheimer’s Disease Research

Malaz Boustani, M.D., MPH, Paul Dexter, M.D., Zina Ben Miled, PhD, M.S.

Dementia risk prediction: Zero-minute assessment at less than a dollar cost

Risk detection is important for care management and may alter course of the disease INDIANAPOLIS – A new study

Joshua Vest, PhD, MPH

Regenstrief Institute researcher appointed associate dean for research at IU Indianapolis Fairbanks School of Public Health

Regenstrief Institute Research Scientist Joshua Vest, PhD, MPH, has been appointed associate dean for research at the Indiana University

Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation

Title: Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation Published in the journal JAMA Neurology. Here is